Thus, it is likely that activation of Nrf2/HO-1 pathway by the PI3K/Akt signaling is, at least partially, responsible for EGCG-mediated attenuation of oxidative damage during IDD. The gene discussed is AKT1; the disease is intervertebral disk degenerative disorder.